• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of tertial structure and function of non-toxic components associating with Clostridium botulinum neurotoxins.

Research Project

Project/Area Number 14370093
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Bacteriology (including Mycology)
Research InstitutionOKAYAMA UNIVERSITY

Principal Investigator

OGUMA Keiji  Okayama University, Graduate School of Medicine and Dentistry, Professor, 大学院・医歯学総合研究科, 教授 (00002262)

Co-Investigator(Kenkyū-buntansha) NISHIKAWA Jun  Tokyo University of Agriculture and Technology, Agriculture, Assistant Professor, 農学部, 助教授 (30218127)
FUJINAGA Yukako  Okayama University, Graduate School of Medicine and Dentisitry, Assistant Researcher, 大学院・医歯学総合研究科, 助手 (60252954)
YOKOTA Kenji  Okayama University, Graduate School of Medicine and Dentisitry, Lecturer, 大学院・医歯学総合研究科, 講師 (00243460)
INOUE Kaoru  National Institute of Environmental Health Sciences, Visiting Associate, Visiting Associate (40260103)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥13,400,000 (Direct Cost: ¥13,400,000)
Fiscal Year 2003: ¥6,200,000 (Direct Cost: ¥6,200,000)
Fiscal Year 2002: ¥7,200,000 (Direct Cost: ¥7,200,000)
KeywordsBotulinum Toxin / Neurotoxin / Progenitor toxin / Hemagglutinin / Binding / Receptor / β-trefoil domain / Siglec family / Neurotoxin / Hemaggultinin / Lactose / Sialic acid / Hemagglutinin
Research Abstract

Clostridium botulinum type A to D hemagglutinin positive progenitor toxins (PTX) consist of three distinct components : neurotoxin (NTX), hemagglutinin (HA), and non-toxic non-HA (NTNH). The HA consists of four subcomponents designated HA1 (〜33kDa), 2 (〜17kDa), 3a (〜22kDa), and 3b (〜53kDa).
We have established an easy procedure for purifying type B HA-positive PTX and NTX by employing an affinity gel column-linked lactose. By employing the purified type A to D toxins and their each HA subcomponents prepared as GST-fusion proteins, we have shown that HA, especially HA1 and HA3b, works as an adhesin in the attachment of HA-positive PTXs to the-microvilli of the upper small intestine as well as erythrocytes. Type A (and B) toxin bound to the galactose mainly via HA1, whereas type C (and D) bound to the sialic acid mainly via HA3b. By analyses of primary and tertiary structure of HA1 and HA3b, It became clear that HA1 has two β-trefoil domains like as lectin B-chain of the ricin, whereas HA3b has carbohydrate recognition domain (CRD) of sialo-adhesin family (or Siglec family). In the binding and internalization tests with C HA-positive toxin and human colon carcinoma HT-29 cells, the toxin bound to glycoproteins with high molecular mass, and internalized within 4 min, but not if the cells were pretreated with neuraminidase, indicating that sialic acid of glycoprotein is the receptor for type C toxin and the toxin can internalize quickly into the cells. It was also found that both HA1 and HA3b have adjuvant activity.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (65 results)

All Other

All Publications (65 results)

  • [Publications] Fujinaga Y, et al.: "Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes."Microbiol.. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arimitsu H, et al.: "Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum type C and D neurotoxins."Clin.Diagn.Lab.Immunol.. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Inoue K, et al.: "Structural analysis by X-ray crystallography and calorimentry of a hemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum."Microbiol.. 149. 3361-3370 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sagane Y, et al.: "Molecular characterization of GroES and GroEL homologues from Clostridium botulinum"J.Protein.Chem.. 22. 99-108 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Furuse T, et al.: "Passive length-tensile properties of extraocular muscles under botulinum toxin type C."Jpn.J.Ophthalmol.. 47. 145-150 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Woodward LA, et al.: "Expression of Hc subunit from Clostridium botulinum types C and D their evaluation as candi date vaccine antigens"Infect.Immun.. 71. 2941-2944 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arimitsu H, et al.: "Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with Dystonia."Infect Immun.. 71. 1599-1603 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nazira M, et al.: "Characterization of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin."J.Med.Microbiol.. 51. 286-294 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sagane Y, et al.: "Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex."Biochem.Biophysic Res.Communi.. 292. 434-440 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nazira M, et al.: "Mucosal immunisation with Clostridium botulinum type C 16S toxioidandits non-toxic component."J.Med.Microbiol.. 51. 813-820 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊惠二: "日本医事新報No.4150(ボツリヌス神経毒素の放出機序)"日本医事新報社. (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊惠二ら: "日常医療に役立つ小児感染症マニュアル2003-2004(ボツリヌス菌)"東京医学社. 20 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二: "ボツリヌス菌.化学療法の領域"医薬ジャーナル. 323-327 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二: "ボツリヌス毒素.化学療法の領域.特集:バイオテロリズム対応策"医学ジャーナル. 347-352 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二: "乳児ボツリヌス症"小児科臨床. 1291-1300 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二: "細菌毒素ハンドブック 概説III 細菌毒素の応用"サイエンスフォーラム. 17-22 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小崎 俊司ら: "細菌毒素ハンドブック ボツリヌス毒素"サイエンスフォーラム. 86-94 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 首藤文榮ら: "細菌毒素ハンドブック C_3酵素"サイエンスフォーラム. 105-112 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二ら: "人獣共通感染症(ボツリヌス症)"医薬ジャーナル(In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二: "日本食品微生物学会雑誌(ボツリヌス毒素およびボツリヌス中毒について)"Jpn.Food.Microbiol.(In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二ら: "病原菌の今日的意味(ボツリヌス菌)"医学ジャーナル. 12 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊惠二: "ハリソン内科学(破傷風、ボツリヌス中毒、ガス炭疽など)"メディカル・サイエンス・インターナショナル. 110 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊惠二: "医学大辞典(嫌気性菌(他))"医学書院. (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊惠二ら: "診断と治療(特集) (ボツリヌス毒素の構造と標的細胞に対する作用)"診断と治療社. 9 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 小熊 惠二: "脳21 「特集2」ボツリヌス療法の現状と将来の展望 ボツリヌス毒素の基礎知識"金芳堂. 53-60 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 笹川伸之ら: "特集:新開発の機械・装置II 食品細菌の自動検査装置「バクテクター」の開発"食品工業. 40-49 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujinaga Y, Inoue K, Watarai S, Sakaguchi Y, Arimitsu H, Lee J, Jin Y, Matsumura T, Kabumoto Y, Watanabe T, Ohyama T, Nishikawa A.: "Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes."Microbiol.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arimitsu H, Lee J, Sakaguchi Y, Hayakawa Y, Hayashi M, Nakaura M, Takai H, Lin SN, Mukamoto M, Murphy T, Oguma K.: "Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum type C and D neurotoxins."Clin.Diagn.Lab.Immunol.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Furuse T, Hasebe S, Ohtsuki H. Oguma K.: "Passive length-tensile properties of extraocular muscles under botulinum toxin type C."Jpn.J.Ophthalmol.. 47. 145-150 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arimitsu H, Inoue K, Sakaguchi Y, Lee J, Fujinaga Y, Watanabe T, Ohyama T, Hirst R, Oguma K.: "Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with Dystonia."Infect.Immun.. 71. 1599-1603 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Woodward LA, Arimitsu H, Hirst R, Oguma K.: "Expression of He subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice."Infect.Immun.. 71. 2941-2944 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sagane Y, Hasegawa K, Mutoh S, Kouguchi H, Suzuki T, Sunagawa H, Nakagawa T, Kamaguchi A, Okasaki S, Nakayama K, Watanabe T, Ohyama T.: "Molecular characterization of GroES and GroEL homologues from Clostridium botulinum."J.Protein.Chem.. 22. 99-108 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Inoue K, Transue TR, Oguma K, Pederson LC, Negishi M.: "Structural analysis by X-ray crystallography and calorimentry of a hemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum."Microbiol.. 149. 3361-3370 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Mahmut N, Inoue K, Fujinaga Y, Hughes L, Arimitsu H, Sakaguchi Y, Ohtsuka A, Murakami T, Yokota K, Oguma K.: "Characterization of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin."J.Med.Microbiol.. 51. 286-294 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sagane Y, Watanabe T, Kouguchi H, Sunagawa H, Obata S, Oguma K, Ohyama T.: "Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex."Biochem.Biophysic Res.Communi.. 292. 434-440 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Mahmut N, Inoue K, Fujinaga Y, Arimitsu H, Sakaguchi Y, Hughes L, Hirst R, Murphy T, Tsuji T, Watanabe T, Ohyama T, Karasawa T, Nakamura S, Yokota K, Oguma K.: "Mucosal immunisation with Clostridium botulinum type C 16S toxioid and its non-toxic component."J.Med.Microbiol.. 51. 813-820 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujinaga Y, et al.: "Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal cells and erythrocytes."Microbiol.. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Arimitsu H, et al.: "Vaccination with recombinant whole heavy chain fragments of Clostridium botulium type C and D neurotoxins."Clin.Diagn.Lab.Immunol.. (in press).

    • Related Report
      2003 Annual Research Report
  • [Publications] Inoue K, et al.: "Structural analysis by X-ray crystallography and calorimentry of a hemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum."Microbiol.. 149. 3361-3370 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Sagane Y, et al.: "Molecular characterization of GroES and GroEL homologues from Clostridium botulium."J.Protein.Chem.. 22. 99-108 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Woodward LA, et al.: "Expression of Hc subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice."Infect.Immun.. 71. 2941-2944 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Arimitsu H, et al.: "Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with Dystonia."Infect.Immun.. 71. 1599-1603 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Furuse T, et al.: "Passive length-tensile properties of extraocular muscles under botulinum toxin type C."Jpn.J.Ophthalmol.. 47. 145-150 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小熊 惠二ら: "病原菌の今日的意味(ボツリヌス菌)"医学ジャーナル. 12 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小熊惠二ら: "ハリソン内科学(破傷風、ボツリヌス中毒、ガス炭疽など)"メディカル・サイエンス・インターナショナル. 110 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小熊惠二ら: "医学大辞典(嫌気性菌(他))"医学書院. (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小熊惠二ら: "診断と治療(特集) ボツリヌス毒素の構造と標的細胞に対する作用"診断と治療社. 9 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小熊惠二ら: "日本医事新報No.4150 ボツリヌス神経毒素の放出機序"日本医事新報社. (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 小熊惠二ら: "日常医療に役立つ小児感染症マニュアル2003-2004(ボツリヌス菌)"東京医学社. 20 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Furuse T, et al.: "Passive length-tensile properties of extraocular muscles under botulinum toxin type C"Jpn. J. Ophthalmol.. (in press).

    • Related Report
      2002 Annual Research Report
  • [Publications] Hughes L, et al.: "Expression of Hc subunit from Clostridium botulinum types C and D their evaluation as candidate vaccine antigens"Infect.Immun. (in press).

    • Related Report
      2002 Annual Research Report
  • [Publications] Arimitsu H, et al.: "Purification of fully activated Clostridiuim botulinum serotype B toxin for treatment of patients with Dystonia"Infect Immun.. 71. 1599-1603 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nazira M, et al.: "Characterization of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin"J. Med. Microbiol.. 51. 286-294 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sagane Y, et al.: "Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex"Biochem. Biophysic Res. Communi.. 292. 43-440 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nazira M, et al.: "Mucosal immunisation with Clostridium botulinum type C 16S toxioid and its non-toxic component"J.Med.Microbiol.. 51. 813-820 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "人獣共通感染症 ボツリヌス症"医薬ジャーナル(in press).

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "病原菌の今日的意味 ボツリヌス菌"医学ジャーナル社. 289-305 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "ボツリヌス菌.化学療法の領域"医薬ジャーナル. 323-327 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "ボツリヌス毒素.化学療法の領域.特集:バイオテロリズム対応策"医学ジャーナル. 347-352 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "乳児ボツリヌス症"小児科臨床. 1291-1300 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "細菌毒素ハンドブック 概説III 細菌毒素の応用"サイエンスフォーラム. 17-22 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小崎 俊司: "細菌毒素ハンドブック ボツリヌス毒素"サイエンスフォーラム. 86-94 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 首藤文榮: "細菌毒素ハンドブック C_3酵素"サイエンスフォーラム. 105-112 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 小熊 惠二: "脳21「特集 2」ボツリヌス療法の現状と将来の展望 ボツリヌス毒素の基礎知識"金芳堂. 53-60 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 笹川伸之: "特集:新開発の機械・装置II 食品細菌の自動検査装置「バクテクター」の開発"食品工業. 40-49 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi